Viracta Therapeutics President and Chief Executive Officer Dr. Ivor Royston Receives the Science History Institute’s Biotechnology Heritage Award

SAN DIEGO, June 13, 2022 /PRNewswire/ — Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced that its President and Chief Executive Officer, Ivor Royston, M.D., is being presented with the Science History…

Click here to view original post